BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22473092)

  • 1. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
    Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
    Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
    Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.
    Uemura M; Hoshiyama M; Furukawa A; Sato T; Higuchi Y; Komeda S
    Metallomics; 2015 Nov; 7(11):1488-96. PubMed ID: 26393664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides.
    Uemura M; Komeda S
    J Inorg Biochem; 2017 Dec; 177():359-367. PubMed ID: 28893417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.
    Komeda S; Yoneyama H; Uemura M; Muramatsu A; Okamoto N; Konishi H; Takahashi H; Takagi A; Fukuda W; Imanaka T; Kanbe T; Harusawa S; Yoshikawa Y; Yoshikawa K
    Inorg Chem; 2017 Jan; 56(2):802-811. PubMed ID: 28045514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.
    Uemura M; Yoshikawa Y; Yoshikawa K; Sato T; Mino Y; Chikuma M; Komeda S
    J Inorg Biochem; 2013 Oct; 127():169-74. PubMed ID: 23725767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
    Yoshikawa Y; Komeda S; Uemura M; Kanbe T; Chikuma M; Yoshikawa K; Imanaka T
    Inorg Chem; 2011 Nov; 50(22):11729-35. PubMed ID: 22004345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.
    Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
    J Inorg Biochem; 2019 Mar; 192():82-86. PubMed ID: 30612029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circular dichroism study uncovers a two-step interaction of antitumor azolato-bridged dinuclear platinum(II) complexes with calf thymus DNA.
    Uemura M; Yoshikawa Y; Chikuma M; Komeda S
    Metallomics; 2012 Jul; 4(7):641-4. PubMed ID: 22538714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA conformation and repair of polymeric natural DNA damaged by antitumor azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Kasparkova J; Suchankova T; Komeda S; Brabec V
    J Inorg Biochem; 2012 Sep; 114():15-23. PubMed ID: 22687561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study.
    Deubel DV
    J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of Fluorine into Antitumor-Active Dinuclear Platinum(II) Complexes Leads to Modulation of
    Uemura M; Hiramoto K; Yoneyama H; Harusawa S; Komeda S
    Inorg Chem; 2022 Aug; 61(31):12155-12164. PubMed ID: 35876345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of ammonia ligands of the antitumor agent cisplatin: a unique dodecanuclear Pt4,Pd4,Ag4 platform for four cytosine model nucleobases.
    Kampf G; Sanz Miguel PJ; Morell Cerdà M; Willermann M; Schneider A; Lippert B
    Chemistry; 2008; 14(23):6882-91. PubMed ID: 18576415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs.
    Kalayda GV; Zhang G; Abraham T; Tanke HJ; Reedijk J
    J Med Chem; 2005 Aug; 48(16):5191-202. PubMed ID: 16078838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.